A detailed history of Vestal Point Capital, LP transactions in Immatics N.V. stock. As of the latest transaction made, Vestal Point Capital, LP holds 2,750,000 shares of IMTX stock, worth $25.7 Million. This represents 2.38% of its overall portfolio holdings.

Number of Shares
2,750,000
Previous 1,200,000 129.17%
Holding current value
$25.7 Million
Previous $12.6 Billion 153.37%
% of portfolio
2.38%
Previous 1.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$9.78 - $13.49 $15.2 Million - $20.9 Million
1,550,000 Added 129.17%
2,750,000 $32 Billion
Q1 2024

May 13, 2024

SELL
$10.23 - $12.94 $9.21 Million - $11.6 Million
-900,000 Reduced 42.86%
1,200,000 $12.6 Billion
Q4 2023

Feb 13, 2024

BUY
$7.36 - $10.89 $15.5 Million - $22.9 Million
2,100,000 New
2,100,000 $22.1 Billion

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $711M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.